Stock listing

Xetra:ABL Abbott Laboratories Aktie

German listing (Xetra) of Abbott Laboratories · home listing NYSE:ABT

Follow Abbott Laboratories into a list and get an email when it puts out news.

Share price · XETR:ABL

€92.68 EUR +0.80 (+0.9%)

Close on Oct 27, 2026

Day range
€91.70 – €93.84 EUROct 27, 2026
Volume
469 sharesOct 27, 2026
Market cap
€161.4B EURAt the close on Oct 27, 2026 · price × 1.74B shares outstanding
Abbott Laboratories logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:ABT · Home$106.20 USD+1.63 (+1.6%)8,439,574$106.15$106.85$104.60$104.57Close on Oct 30, 2026
Xetra:ABL€92.68 EUR+0.80 (+0.9%)469€93.68€93.84€91.70€91.88Close on Oct 27, 2026
BMV:ABT$1,928.00 MXN+5.00 (+0.3%)633$1,930.00$1,932.88$1,928.00$1,923.00Close on Oct 23, 2026
B3:ABTT3446.10 BRL+3.06 (+7.1%)8746.6046.6045.8543.04Close on Oct 27, 2026
Cboe Canada:ABT$18.03 CAD-0.07 (-0.4%)1,000$17.91$18.13$17.91$18.10Close on Oct 27, 2026
Stuttgart:ABL€91.36 EUR—6€88.96€91.36€88.86—Close on Oct 22, 2026
Frankfurt:ABL€94.52 EUR+2.30 (+2.5%)132€93.90€94.52€93.90€92.22Close on Oct 30, 2026
LSE:0Q15$103.31 USD-0.06 (-0.1%)28,477$103.02$105.70$101.83$103.37Close on Oct 27, 2026
Munich:ABL€93.76 EUR+2.58 (+2.8%)—€93.76€93.76€93.76€91.18Close on Oct 27, 2026
Hamburg:ABL€95.14 EUR+2.58 (+2.8%)—€94.00€95.14€93.66€92.56Close on Oct 30, 2026
Dusseldorf:ABL€94.74 EUR+1.90 (+2.0%)—€93.90€94.82€93.56€92.84Close on Oct 30, 2026
Ticker
Xetra:ABL
Asset type
Stock
Exchange
Xetra
Currency
EUR

What changed lately

Calls

Replays

  • Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings Call

    Wed, Oct 21, 2026 · 9:00 AM ET

    Watch Transcript

  • Abbott Laboratories (NYSE:ABT) Q2 2026 Earnings Call

    Thu, Jul 16, 2026 · 9:00 AM ET

    Watch Transcript

  • Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call

    Thu, Apr 16, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke

Nov 2, 2026

Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

Nov 1, 2026

Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease

Oct 29, 2026

Abbott Laboratories receives FDA approval for first and only device in the U.S. to treat leaks after heart valve replacement without additional surgery

Oct 28, 2026

Abbott launches whole-genome sequencing Oncodetect® molecular residual disease (MRD) test to detect traces of cancer during and after treatment

Oct 26, 2026

Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer

Oct 23, 2026

Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance

Oct 21, 2026

Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company

Oct 21, 2026

Abbott's Cologuard Plus® receives CE Mark for colorectal cancer screening in Europe

Oct 20, 2026

Abbott Laboratories Reports New Real-World Evidence Linking Cologuard Screening to Lower Colorectal Cancer Incidence and Odds of Death

Oct 12, 2026

All Abbott Laboratories news

Decks

Abbott Laboratories on 6ix

News releases
82 in the last 12 months · 107 in all · newest Nov 2, 2026 · oldest 2025
Calls
32 calls with a replay · 32 with a transcript · latest Oct 21, 2026
Decks
18 decks · latest Nov 20, 2025

Where Abbott Laboratories is listed

ListingExchangeCountryCurrency
NYSE:ABT · Home listingNYSEUnited StatesUSD
gettex:ABLgettexGermanyEUR
BCBA:ABTBCBAArgentinaARS
Xetra:ABL · This pageXetraGermanyEUR
TSX:ABTTSXCanadaCAD
Tradegate:ABLTradegateGermanyEUR
BCBA:ABTDBCBAArgentinaUSD
BMV:ABTBMVMexicoMXN
LS Exchange:850103LS ExchangeGermanyEUR
B3:ABTT34B3BrazilBRL
Cboe Canada:ABTCboe CanadaCanadaCAD
Stuttgart:ABLStuttgartGermanyEUR
BCBA:ABTCBCBAArgentinaUSD
Frankfurt:ABLFrankfurtGermanyEUR
LSE:0Q15LSEUnited KingdomUSD
Milan:1ABTMilanItalyEUR
Lang & Schwarz:850103Lang & SchwarzGermanyEUR
SIX Swiss:ABTSIX SwissSwitzerlandCHF
BOATS:ABTBOATSUnited StatesUSD
VIE:ABTViennaAustriaEUR
BCS:ABTCLBCSChileCLP
BCS:ABTBCSChileUSD
Turquoise:ABTNTurquoiseUnited KingdomUSD
Munich:ABLMunichGermanyEUR
Aquis:ABLDAquisUnited KingdomEUR
Hamburg:ABLHamburgGermanyEUR
Hanover:ABLHanoverGermanyEUR
BSESOF:ABLBSESOFBulgariaEUR
BX Swiss:ABLBX SwissSwitzerlandCHF
BCBA:ABTBBCBAArgentinaARS
Dusseldorf:ABLDusseldorfGermanyEUR
BIVA:ABTBIVAMexicoMXN
BCBA:ABTDBBCBAArgentinaUSD
BVL:ABTUSBVLPeruPEN
BCBA:ABTCBBCBAArgentinaUSD
Aquis:ABLDAquisUnited KingdomEUR
Frankfurt:ABL0FrankfurtGermanyEUR
BCBA:ABT.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Abbott Laboratories.